Click here to get full coverage on Using Ichimoku Cloud for BIIB technicals - July 2025 Retail & Safe Swing Trade Setups - newser.com

Using Ichimoku Cloud for BIIB technicals - July 2025 Retail & Safe Swing Trade Setups  newser.com

Using Ichimoku Cloud for BIIB technicals - July 2025 Retail & Safe Swing Trade Setups - newser.com

Click here to get full coverage on Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB - MarketBeat

Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB  MarketBeat

Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen Inc. (BIIB): A Bull Case Theory - Yahoo Finance

Biogen Inc. (BIIB): A Bull Case Theory  Yahoo Finance

Biogen Inc. (BIIB): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) breakout and retrace signals buying opportunity - FXStreet

Biogen (BIIB) breakout and retrace signals buying opportunity  FXStreet

Biogen (BIIB) breakout and retrace signals buying opportunity - FXStreet

Click here to get full coverage on BofA Securities Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $167 - 富途牛牛

BofA Securities Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $167  富途牛牛

BofA Securities Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $167 - 富途牛牛

Click here to get full coverage on Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story? - simplywall.st

Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story?  simplywall.st

Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story? - simplywall.st

Click here to get full coverage on Patient Opportunity Equity strategy buys UNH, CROX, MAT, IAC, and BIIB - Seeking Alpha

Patient Opportunity Equity strategy buys UNH, CROX, MAT, IAC, and BIIB  Seeking Alpha

Patient Opportunity Equity strategy buys UNH, CROX, MAT, IAC, and BIIB - Seeking Alpha

Click here to get full coverage on Why BIIB stock remains undervalued - 2025 Key Highlights & Growth Focused Entry Reports - nchmf.gov.vn

Why BIIB stock remains undervalued - 2025 Key Highlights & Growth Focused Entry Reports  nchmf.gov.vn

Why BIIB stock remains undervalued - 2025 Key Highlights & Growth Focused Entry Reports - nchmf.gov.vn

Click here to get full coverage on Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str - GuruFocus

Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str  GuruFocus

Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str - GuruFocus

Click here to get full coverage on Can BIIB stock sustain free cash flow growth - July 2025 Chart Watch & Community Trade Idea Sharing Platform - newser.com

Can BIIB stock sustain free cash flow growth - July 2025 Chart Watch & Community Trade Idea Sharing Platform  newser.com

Can BIIB stock sustain free cash flow growth - July 2025 Chart Watch & Community Trade Idea Sharing Platform - newser.com

Click here to get full coverage on Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB - MarketBeat

Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB  MarketBeat

Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT - Yahoo Finance

Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT  Yahoo Finance

Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Valuation: Assessing Market Discount After Recent Signs of Financial Stabilization - simplywall.st

Biogen (BIIB) Valuation: Assessing Market Discount After Recent Signs of Financial Stabilization  simplywall.st

Biogen (BIIB) Valuation: Assessing Market Discount After Recent Signs of Financial Stabilization - simplywall.st

Click here to get full coverage on Loss Report: Will BIIB stock return to pre crisis levels - Portfolio Value Summary & High Conviction Buy Zone Alerts - nchmf.gov.vn

Loss Report: Will BIIB stock return to pre crisis levels - Portfolio Value Summary & High Conviction Buy Zone Alerts  nchmf.gov.vn

Loss Report: Will BIIB stock return to pre crisis levels - Portfolio Value Summary & High Conviction Buy Zone Alerts - nchmf.gov.vn

Click here to get full coverage on Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB - MarketBeat

Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB  MarketBeat

Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB - MarketBeat

TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB  MarketBeat

TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB - MarketBeat

Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB  MarketBeat

Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB - MarketBeat

Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB  MarketBeat

Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB - MarketBeat

Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB  MarketBeat

Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on BIIB Stock: Is Biogen Still A Buy After The 14% Spike? - Forbes

BIIB Stock: Is Biogen Still A Buy After The 14% Spike?  Forbes

BIIB Stock: Is Biogen Still A Buy After The 14% Spike? - Forbes

Click here to get full coverage on Can BIIB stock sustain market leadership - Insider Buying & Real-Time Volume Triggers - nchmf.gov.vn

Can BIIB stock sustain market leadership - Insider Buying & Real-Time Volume Triggers  nchmf.gov.vn

Can BIIB stock sustain market leadership - Insider Buying & Real-Time Volume Triggers - nchmf.gov.vn

Click here to get full coverage on 3 Reasons BIIB is Risky and 1 Stock to Buy Instead - The Globe and Mail

3 Reasons BIIB is Risky and 1 Stock to Buy Instead  The Globe and Mail

3 Reasons BIIB is Risky and 1 Stock to Buy Instead - The Globe and Mail

Click here to get full coverage on Biogen (BIIB): Revisiting Valuation After Recent Pipeline and Partnership Developments - Yahoo Finance

Biogen (BIIB): Revisiting Valuation After Recent Pipeline and Partnership Developments  Yahoo Finance

Biogen (BIIB): Revisiting Valuation After Recent Pipeline and Partnership Developments - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued - Yahoo Finance

Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued  Yahoo Finance

Biogen (BIIB) Expands Neurology Pipeline With Alcyone Buyout, Stock Seen Undervalued - Yahoo Finance

Click here to get full coverage on Chart Watch: Can BIIB stock deliver sustainable ROE - Market Volume Report & Low Risk High Reward Trade Ideas - nchmf.gov.vn

Chart Watch: Can BIIB stock deliver sustainable ROE - Market Volume Report & Low Risk High Reward Trade Ideas  nchmf.gov.vn

Chart Watch: Can BIIB stock deliver sustainable ROE - Market Volume Report & Low Risk High Reward Trade Ideas - nchmf.gov.vn

Click here to get full coverage on Hourglass Capital LLC Purchases Shares of 17,970 Biogen Inc. $BIIB - MarketBeat

Hourglass Capital LLC Purchases Shares of 17,970 Biogen Inc. $BIIB  MarketBeat

Hourglass Capital LLC Purchases Shares of 17,970 Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Why Biogen (BIIB) Is Up 6.4% After At-Home Alzheimer’s Therapy and Dravet Data Updates - Yahoo Finance

Why Biogen (BIIB) Is Up 6.4% After At-Home Alzheimer’s Therapy and Dravet Data Updates  Yahoo Finance

Why Biogen (BIIB) Is Up 6.4% After At-Home Alzheimer’s Therapy and Dravet Data Updates - Yahoo Finance

Click here to get full coverage on NorthRock Partners LLC Invests $391,000 in Biogen Inc. $BIIB - MarketBeat

NorthRock Partners LLC Invests $391,000 in Biogen Inc. $BIIB  MarketBeat

NorthRock Partners LLC Invests $391,000 in Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Generali Asset Management SPA SGR Purchases 2,518 Shares of Biogen Inc. $BIIB - MarketBeat

Generali Asset Management SPA SGR Purchases 2,518 Shares of Biogen Inc. $BIIB  MarketBeat

Generali Asset Management SPA SGR Purchases 2,518 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Is Biogen Now an Opportunity After Recent 25% Share Price Decline? - simplywall.st

Is Biogen Now an Opportunity After Recent 25% Share Price Decline?  simplywall.st

Is Biogen Now an Opportunity After Recent 25% Share Price Decline? - simplywall.st

Click here to get full coverage on H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects - Yahoo Finance

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects  Yahoo Finance

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects - Yahoo Finance

Click here to get full coverage on J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround - The Motley Fool

J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround  The Motley Fool

J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround - The Motley Fool

Click here to get full coverage on Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat

Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB)  MarketBeat

Wedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB) - MarketBeat

Click here to get full coverage on (BIIB) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

(BIIB) Movement Within Algorithmic Entry Frameworks  news.stocktradersdaily.com

(BIIB) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Click here to get full coverage on BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL - Yahoo Finance

BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL  Yahoo Finance

BIIB's sNDA for Higher Dose of SMA Drug Spinraza Gets FDA's CRL - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Valuation in Focus After FDA Nod for At-Home Leqembi, Dravet Therapy Progress - simplywall.st

Biogen (BIIB) Valuation in Focus After FDA Nod for At-Home Leqembi, Dravet Therapy Progress  simplywall.st

Biogen (BIIB) Valuation in Focus After FDA Nod for At-Home Leqembi, Dravet Therapy Progress - simplywall.st

Click here to get full coverage on Biogen (BIIB) to Report Q3 Earnings Amid IPR&D Expense Impact - GuruFocus

Biogen (BIIB) to Report Q3 Earnings Amid IPR&D Expense Impact  GuruFocus

Biogen (BIIB) to Report Q3 Earnings Amid IPR&D Expense Impact - GuruFocus

Click here to get full coverage on Biogen (BIIB) Stock Is Up, What You Need To Know - Yahoo Finance

Biogen (BIIB) Stock Is Up, What You Need To Know  Yahoo Finance

Biogen (BIIB) Stock Is Up, What You Need To Know - Yahoo Finance

Click here to get full coverage on Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries - Yahoo Finance

Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries  Yahoo Finance

Biogen Inc. (BIIB)’s Alzheimer’s Drug Leqembi Wins EU Nod, Now Approved in 48 Countries - Yahoo Finance

Click here to get full coverage on BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance - Yahoo Finance

BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance  Yahoo Finance

BIIB Q2 Deep Dive: New Launches Offset Legacy Pressure, Pipeline Advancements Drive Guidance - Yahoo Finance

Click here to get full coverage on Is Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength? - Yahoo Finance

Is Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength?  Yahoo Finance

Is Global Expansion of LEQEMBI Enough to Reinforce Biogen’s (BIIB) Long-Term Pipeline Strength? - Yahoo Finance

Click here to get full coverage on Biogen (NASDAQ:BIIB) Reports Bullish Q2 - Yahoo Finance

Biogen (NASDAQ:BIIB) Reports Bullish Q2  Yahoo Finance

Biogen (NASDAQ:BIIB) Reports Bullish Q2 - Yahoo Finance

Click here to get full coverage on Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way - Yahoo Finance

Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way  Yahoo Finance

Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way - Yahoo Finance

Click here to get full coverage on Canaccord Genuity Reiterates a Buy on Biogen (BIIB) - Yahoo Finance

Canaccord Genuity Reiterates a Buy on Biogen (BIIB)  Yahoo Finance

Canaccord Genuity Reiterates a Buy on Biogen (BIIB) - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $BIIB Given $149.0 Price Target - Quiver Quantitative

New Analyst Forecast: $BIIB Given $149.0 Price Target  Quiver Quantitative

New Analyst Forecast: $BIIB Given $149.0 Price Target - Quiver Quantitative

Click here to get full coverage on Wedbush Comments on Biogen's FY2025 Earnings (NASDAQ:BIIB) - MarketBeat

Wedbush Comments on Biogen's FY2025 Earnings (NASDAQ:BIIB)  MarketBeat

Wedbush Comments on Biogen's FY2025 Earnings (NASDAQ:BIIB) - MarketBeat

Click here to get full coverage on Biogen (NASDAQ:BIIB) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Biogen (NASDAQ:BIIB) Stock Rating Upgraded by Wall Street Zen  MarketBeat

Biogen (NASDAQ:BIIB) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Click here to get full coverage on 3 Reasons BIIB is Risky and 1 Stock to Buy Instead - Yahoo Finance

3 Reasons BIIB is Risky and 1 Stock to Buy Instead  Yahoo Finance

3 Reasons BIIB is Risky and 1 Stock to Buy Instead - Yahoo Finance

Click here to get full coverage on Biogen's Comeback: Why The Bulls Are Finally Winning Again (NASDAQ:BIIB) - Seeking Alpha

Biogen's Comeback: Why The Bulls Are Finally Winning Again (NASDAQ:BIIB)  Seeking Alpha

Biogen's Comeback: Why The Bulls Are Finally Winning Again (NASDAQ:BIIB) - Seeking Alpha

Click here to get full coverage on Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for  Yahoo Finance

Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance

Biogen (BIIB) Stock Trades Down, Here Is Why  Yahoo Finance

Biogen (BIIB) Stock Trades Down, Here Is Why - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates  Yahoo Finance

Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Click here to get full coverage on Aberdeen Group plc Purchases 9,942 Shares of Biogen Inc. $BIIB - MarketBeat

Aberdeen Group plc Purchases 9,942 Shares of Biogen Inc. $BIIB  MarketBeat

Aberdeen Group plc Purchases 9,942 Shares of Biogen Inc. $BIIB - MarketBeat

Click here to get full coverage on Biogen Earnings: What To Look For From BIIB - Yahoo Finance

Biogen Earnings: What To Look For From BIIB  Yahoo Finance

Biogen Earnings: What To Look For From BIIB - Yahoo Finance

Click here to get full coverage on Biogen (NASDAQ:BIIB) Trading 8.1% Higher - Still a Buy? - MarketBeat

Biogen (NASDAQ:BIIB) Trading 8.1% Higher - Still a Buy?  MarketBeat

Biogen (NASDAQ:BIIB) Trading 8.1% Higher - Still a Buy? - MarketBeat

Click here to get full coverage on Biogen (BIIB) Gains as LEQEMBI Wins Australian Approval for Early Alzheimer’s Treatment - simplywall.st

Biogen (BIIB) Gains as LEQEMBI Wins Australian Approval for Early Alzheimer’s Treatment  simplywall.st

Biogen (BIIB) Gains as LEQEMBI Wins Australian Approval for Early Alzheimer’s Treatment - simplywall.st

Click here to get full coverage on Insider Sale: Head of Development of $BIIB Sells 517 Shares | BIIB Stock News - Quiver Quantitative

Insider Sale: Head of Development of $BIIB Sells 517 Shares | BIIB Stock News  Quiver Quantitative

Insider Sale: Head of Development of $BIIB Sells 517 Shares | BIIB Stock News - Quiver Quantitative

Click here to get full coverage on Jefferies Initiates Coverage of Biogen (BIIB) with Buy Recommendation - Nasdaq

Jefferies Initiates Coverage of Biogen (BIIB) with Buy Recommendation  Nasdaq

Jefferies Initiates Coverage of Biogen (BIIB) with Buy Recommendation - Nasdaq

Click here to get full coverage on Biogen (NASDAQ:BIIB) Price Target Raised to $135.00 - MarketBeat

Biogen (NASDAQ:BIIB) Price Target Raised to $135.00  MarketBeat

Biogen (NASDAQ:BIIB) Price Target Raised to $135.00 - MarketBeat

Click here to get full coverage on “LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China - Stock Titan

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China  Stock Titan

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China - Stock Titan

Click here to get full coverage on Why Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom - Yahoo Finance

Why Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom  Yahoo Finance

Why Biogen Inc. (BIIB) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom - Yahoo Finance

Click here to get full coverage on RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT - Yahoo Finance

RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT  Yahoo Finance

RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT - Yahoo Finance

Click here to get full coverage on We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve  Yahoo Finance

We Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

Click here to get full coverage on Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance

Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates  Yahoo Finance

Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on First-and-only at-home anti-amyloid injection: LEQEMBI IQLIK named to TIME’s Best Inventions 2025 - Stock Titan

First-and-only at-home anti-amyloid injection: LEQEMBI IQLIK named to TIME’s Best Inventions 2025  Stock Titan

First-and-only at-home anti-amyloid injection: LEQEMBI IQLIK named to TIME’s Best Inventions 2025 - Stock Titan

Click here to get full coverage on Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks  Yahoo Finance

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks - Yahoo Finance

Click here to get full coverage on Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance

Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures  Yahoo Finance

BIIB

Price Chart

Key Statistics

Technicals

About BIIB

Latest News

Using Ichimoku Cloud for BIIB technicals - July 2025 Retail & Safe Swing Trade Setups - newser.com

Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB - MarketBeat

Biogen Inc. (BIIB): A Bull Case Theory - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers